Forteo (teriparatide), human parathyroid hormone for treating osteoporosis

January 2003

You'll be hearing about Forteo (teriparatide), human parathyroid hormone for treating osteoporosis.

It's the first osteoporosis drug that actually stimulates new bone growth. Others just slow bone loss.

It appears to be more effective than other therapies. It reduces vertebral fracture risk by up to 65%.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

landmark NIH hypertension study will shake things up
Strattera, the first NON-stimulant drug approved for ADHD
Cardiology how recurrent atrial fibrillation patients are treated
Cardiology You'll be hearing a lot more this year about C-reactive protein
Cardiology statins decrease the effects of Plavix
some patients accidentally overdosing on their methotrexate
Infectious Diseases Copegus, a new ribavirin for hepatitis C
Infectious Diseases how to treat gonorrhea now that Wyeth is discontinuing cefixime (Suprax)
Infectious Diseases Pediarix, the first five-in-one vaccine for infants
Women's Health how to treat women with epilepsy
Women's Health whether to treat asymptomatic urinary tract infections in women with diabetes
Dermatology Aldara (imiquimod cream) to treat actinic keratoses
Dermatology latest treatments for wrinkles
Osteoporosis Forteo (teriparatide), human parathyroid hormone for treating osteoporosis
Is it legal for patients to import prescription drugs
Some patients are getting into trouble because they use the "float test" to see if their metered-dose inhaler is empty